All prescription drugs that desire to be marketed in the U.S. must gain the approval of the Food and Drug Administration (FDA). Through the Center for Drug Evaluation and Research (CDER), which assures that safe and effective drugs are available to the American people, a prescription drug must pass a series of trials. Please understand that the FDA does not develop, manufacture or test drugs. Drug manufacturers submit full reports of a drug’s studies to the CDER so that the Center can evaluate its data. The studies answer the question, “Does this drug work for the proposed use?” By analyzing the data, CDER reviewers assess the benefit-to-risk relationship and determine if the drug will be approved. Once the drug has been placed on the market, the FDA continues to monitor it through post-marketing reports sent in by the manufacturer and through the MedWatch program – an FDA program that allows consumers and health care professionals to report serious side effects, quality control issues, and medical errors associated with drugs and products regulated by the FDA.

Sometimes, an unanticipated side effect manifests itself once the drug has been made available to the U.S. market. If the side effect is serious enough, the FDA may issue a warning to the public and request that changes be made to the drug’s label. If the side effect is extremely serious and the FDA decides that the risks of the drug outweigh its benefits, then the FDA may recall the drug.

Speak to a Lawyer

Each year, thousands of people die from or are seriously injured by prescription drugs, over-the-counter drugs and medical devices they believe to be safe. If you or a loved one have taken a defective drug, experienced problems with a defective medical device or used a defective product, then contact our law firm immediately. Consult an attorney privately to learn your legal rights. All information is held in the strictest of confidence.

Contact a Drug Lawsuit Lawyer & Attorney

For a free and confidential consultation, fill out our online case evaluation form or call us toll free at: 1-800-883-9858.

Contact an Attorney

Legal help: Contact an Attorney

Ethicon Mesh Recall

In June of 2012, the Ethicon, Inc. division of Johnson & Johnson notified the US Food and Drug Administration that it would no longer be offering some of its Gynecare Women’s Health Mesh products. Although this Ethicon mesh recall was voluntary and not mandated by the FDA, Johnson & Johnson will also case to commercialize these products. They will also be notifying physicians and patients in order to allow them the opportunity to select other treatment options. The four products impacted by this mesh recall decision by Ethicon are the following:

  • Ethicon Gynecare Prolift Pelvic Floor Repair System
  • Ethicon Gynecare TVT Secur System
  • Gynecare Prosima Pelvic Floor Repair System
  • Gynecare Prolift+M Pelvic Floor Repair System

Ethicon Mesh FDA Warning

These decisions by Ethicon to recall the advertisements and offering of these mesh products comes following several warnings from the FDA regarding the increased risk of complications associated with the transvaginal use of surgical mesh. As early as 2008, the FDA warned about vaginal mesh following a large number of adverse event reports in the time period between 2008-2007. However, from2008-2010, there were an even larger number of incidents reported. When the US Food and Drug Administration compiled literature regarding Ethicon and other brands of mesh using data from 1996-2011, they were able to conclude that complications from vaginal mesh are NOT RARE and mesh products were deemed an area of ongoing concern.

Ethicon Mesh Recall Lawsuits

The victims of Ethicon Mesh injuries often choose to pursue litigation against the manufacturer of their particular device. At present there is both state and federal level litigation pending against Johnson & Johnson’s Ethicon, Inc. Additionally, mesh recall lawsuits are pending against several other manufacturers as well, including C. R. Bard, Boston Scientific, and American Medical Systems. Many of these mesh lawsuits were filed after the FDA declared that transvaginal mesh did not appear to provide any benefits for patients that would justify the increase in risk and complications.

File an Ethicon Mesh Recall Lawsuit: Attorney Consultation

Have you experienced mesh erosion or other serious injury following treatment with an Ethicon mesh implant? If so, contact the Willis Law Firm today for a free and confidential recall lawsuit consultation. We know that these are potentially embarrassing women’s health issues, so we have female consultants available for your comfort. Currently, we are assessing Ethicon lawsuit claims in all fifty states, and all mesh clients are represented on a fee contingent basis. If we don’t recover for you, you don’t have to pay any legal or attorney’s fees.

Paxil and Pregnancy

Back in 2006, the Food and Drug Administration (FDA) announced that research evaluations of the prescription antidepressant Paxil discovered that taking Paxil during pregnancy, specifically during the first three months of pregnancy, may significantly raise the risk of having an infant with birth defects. The most common Paxil birth defects found were congenital (present at birth) heart defects.

Paxil is a popular antidepressant medication and is part of a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs). SSRI antidepressants work by altering certain chemical levels in the brain used to communicate called neurotransmitters. A lot of scientific experts believe that depression is a result of an imbalance in the numbers of different neurotransmitters in the brain. Other antidepressants in the SSRI class include Zoloft, Prozac, Celexa, and Effexor. Paxil has been approved by the Food and Drug Administration (FDA) to treat depression and certain other psychiatric disorders.

Two studies examined by the Food and Drug Administration (FDA) determined that women who took Paxil during the first trimester of pregnancy were approximately twice as likely to have an infant suffering from a heart defect compared to women who took other antidepressants during pregnancy. The majority of the Paxil heart defects found in the research study were atrial and ventricular septal defects which are holes in the chamber walls in the heart.

Atrial and ventricular septal defects may vary greatly in severity. In some cases they can be fairly minor, and some are more serious which may require operation or even a heart transplant early in life. Among the general population of pregnancies, these types of heart defects occur in about 1 of every 100 births, but in Paxil pregnancies they occur about twice as frequently.

The FDA report has resulted in the manufacturer of Paxil, Glaxo Smith Kline, changing the warning label on their prescription packaging. Where previously it was a pregnancy category C drug, it is now a pregnancy category D drug. This is a significant change because it now recognizes that studies among pregnant women have demonstrated that Paxil causes a risk to unborn children. The FDA is urging medical professionals not to prescribe Paxil to pregnant women or women who are considering becoming pregnant.

Paxil and Pregnancy Lawsuit: Speak to an Attorney

Many new parents ask themselves what was the cause of my child’s birth defects? Did it happen during pregnancy? The antidepressant Paxil may be linked to causing the development of birth defects of unborn babies, infants, and children when their mothers took them while pregnant.

Our law firm is handling individual birth defect lawsuits against drug and pharmaceutical companies and currently accepting new Paxil cases across the nation. If your child was born with a birth injury that you believe may have been caused by taking an antidepressant like Paxil during pregnancy, then you should contact our law firm as soon as possible for a free confidential review of your potential birth defect lawsuit case. All cases are handled on a Contingency Fee Basis (no attorney’s fees or expenses charged unless we recover for you).

Contact a Drug Lawsuit Lawyer & Attorney

For a free and confidential consultation, fill out our online case evaluation form or call us toll free at: 1-800-883-9858.

Contact an Attorney

Legal help: Contact an Attorney

A woman in Pennsylvania recently filed a lawsuit against Boston Scientific Corporation alleging that one of their products, the Advantage Fit System, caused her serious physical complications. The woman was treated with the transvaginal mesh product in 2009 to help with her issue of stress urinary incontinence, an involuntary urine leakage problem that affects many women. According to her mesh lawsuit claim, the woman began to experience pain, bleeding, and extreme discomfort during intercourse shortly following her initial Advantage Fit SUI treatment. These complications related to transvaginal mesh have been described as “not rare,” by the US Food and Drug Administration in various safety communications and warnings. The Pennsylvania Boston Scientific Advantage Fit Lawsuit plaintiff underwent a transvaginal mesh revision surgery in 2010, but continued to experience mesh complications including: stomach pain, bleeding, and infections. As a result of these continuing discomforts as well as the medical expenses required for treatment, a mesh erosion lawsuit claim was filed.

Boston Scientific Advantage Fit FDA Warning

In October of 2008, the United States Food and Drug Administration alerted the public to the complications connected to transvaginal mesh surgery for pelvic organ prolapse and stress urinary incontinence. In the three years prior to the FDA mesh warning, over one thousand adverse event reports were filed in relation to surgical mesh. Between 2008-2010, this number grew closer to 3000. When another FDA transvaginal mesh warning was made in 2010, vaginal mesh complications and mesh erosion were named as “an area of continuing serious concern.” The FDA is still collecting data and reviewing studies regarding Boston Scientific Advantage Fit as well as all other transvaginal mesh sling devices.

Boston Scientific Advantage Fit Complications

  • Mesh erosion (when the mesh protrudes through vaginal walls)
  • Vaginal Pain
  • Mesh contraction (when the mesh shrinks)
  • Organ perforation (can occur during surgery)
  • Pain during intercourse
  • Reoccurrence of SUI and/or POP
  • Vaginal Scarring
  • Emotional problems

File a Boston Scientific Advantage Fit Lawsuit: Consult with an Attorney

Treatment with Boston Scientific Advantage Fit and other transvaginal mesh slings presents additional risks that are not present in other non-mesh forms of treatment for SUI and POP. If you have suffered injuries resulting from surgical mesh, you may have a potential lawsuit claim. Call the Willis Law Firm in order to have your case evaluated free of charge or obligation by a female member of our talented legal team. At present, we are accepting vaginal mesh clients nationwide.

Contact a Drug Lawsuit Lawyer & Attorney

For a free and confidential consultation, fill out our online case evaluation form or call us toll free at: 1-800-883-9858.

Contact an Attorney

Legal help: Contact an Attorney

Recent studies as well as FDA adverse event reports have linked transvaginal mesh surgery for stress urinary incontinence and pelvic organ prolapse to high risks of complications, like mesh erosion. Medical device manufacturer Boston Scientific is one of four major companies that develops and distributes this problematic type of transvaginal mesh. One such model is called the Solyx SIS System, which is a sling made of Advantage Mesh and is used to treat stress urinary incontinence. Unfortunately, the Solyx System as well as all other transvaginal mesh product can result in serious complications that can require hospitalization and revision surgeries. In many patients, even a second surgery cannot fully fix the problem of mesh erosion, and the quality of life for the victim is permanently diminished.

Other Boston Scientific Transvaginal Mesh Products

The Solyx SIS System is not the only mesh device that has been developed and created by the Boston Scientific Corporation. Currently, Boston Scientific has all of the following mesh products available for the treatment of either pelvic organ prolapse, stress urinary incontinence and/or vaginal wall prolapse:

  • Advantage Fit System
  • Advantage Transvaginal Mid-Urethral Sling System
  • Lynx Suprapubic Mid-Urethral Sling System
  • Obtryx Transobturator Mid-Urethral Sling System
  • Pinnacle Pelvic Floor Repair Kit
  • Pinnacle Posterior Pelvic Floor Repair Kit
  • Prefyx PPS System
  • Solyx SIS System
  • Uphold Vaginal Support System

Boston Scientific Solyx FDA Warning

In January of 2012, the United States Food and Drug Administration is considering that transvaginal surgical mesh be reclassified from Class II to Class III when used in treatment for stress urinary incontinence and pelvic organ prolapse. This decision was based on information collected from adverse event reports of vaginal mesh complications, medical literature published on the subject, as well as the September 2011 meeting of the Obstetrics-Gynecology Devices Panel. Furthermore, the FDA has mandated postmarket studies the manufacturers of transvaginal mesh used in both SUI and POP treatment. As soon as further information is discovered regarding Boston Scientific Solyx and other devices, the FDA will make it available to the public.

File a Boston Scientific Transvaginal Mesh Lawsuit: Speak to an Attorney

Many women who suffer from mesh erosion and other bladder sling complications find themselves bombarded with medical expenses as the result of their injuries. If you have been hurt as the result of treatment with the Solyx SIS System or other type of transvaginal mesh, call the Willis Law Firm today. We may be able to help you secure financial damages in relation to your situation; currently we are looking at mesh cases nationwide. Call us today.

Contact a Drug Lawsuit Lawyer & Attorney

For a free and confidential consultation, fill out our online case evaluation form or call us toll free at: 1-800-883-9858.

Contact an Attorney

Legal help: Contact an Attorney

Recently the US Food and Drug Administration has issued several safety communications regarding high risks of serious complications associated with transvaginal mesh, like Ethicon’s Gynecare Prolift System. Many lawsuits have been filed against Ethicon, a division of Johnson & Johnson, by patients who have suffered from painful and even life-threatening adverse effects. Transvaginal mesh bladder slings are used in the treatment of pelvic organ prolapse as well as stress urinary incontinence. However, the FDA has stated that although they pose extra risks to patients, they do not necessarily work better than other non-mesh treatment options.

What is the Ethicon Gynecare Prolift System?

The Gynecare Prolift Pelvic Floor Repair system is a vaginal mesh bladder sling device produced and marketed by Johnson & Johnson’s Ethicon division for the treatment of pelvic organ prolapse. Pelvic organ prolapse (POP) is a condition that takes place when various tissues that hold the organs in the pelvic region become stretched out or weakened. POP can affect the uterus, rectum, bowels, bladder, and vaginal apex. The Gynecare Prolift mesh is transvaginal, meaning that it is inserted through the vagina, and helps to restore support to organs that have prolapsed. Unfortunately, using transvaginal mesh, like the Gynecare Prolift System, can result in harmful complications including: infection, urinary problems, mesh erosion, and others.

Ethicon Gynecare Prolift System Complications

The side effects and complications that can result from transvaginal mesh treatment can seriously affect a patient’s quality of life. The most commonly reported complication with Gynecare Prolift and other similar devices is called mesh exposure, and occurs when the mesh erodes through the vaginal wall. When this erosion takes place, the result is very painful, especially during sexual intercourse. Treatment for these Gynecare Prolift complications often requires a revision surgery in order to remove the mesh, as well as IV treatment and possibly even blood transfusions. Sometimes, even a second surgery cannot fully remove the mesh.

File a Ethicon Gynecare Prolift Lawsuit: Speak to an Attorney

Have you experienced transvaginal mesh erosion or other complications following treatment with the Gynecare Prolift System or similar device? If so, you may be legally entitled to significant financial damages. Call the Willis Law Firm today and we will provide you with a free and confidential Gynecare Prolift Lawsuit Evaluation. Our firm is currently reviewing vaginal mesh cases nationwide, and we have a team of female consultants ready to discuss these sensitive women’s health issues with you in confidence. Call us today, and get the help you need.

Contact a Drug Lawsuit Lawyer & Attorney

For a free and confidential consultation, fill out our online case evaluation form or call us toll free at: 1-800-883-9858.

Contact an Attorney

Legal help: Contact an Attorney

Zoloft FDA Alert

Taking Zoloft while pregnant may lead to an increased risk of several different types of birth defects, many which are potentially life threatening. Over the past few years Zoloft has been linked to congenital heart defects, stomach/abdominal wall defects, cranial/skull defects, Autism Spectrum Disorders, and several other devastating medical conditions. The FDA has released a safety communication regarding the increased risk of one of these conditions, Persistent Pulmonary Hypertension of the Newborn (PPHN). Unfortunately, the FDA still allows for the treatment of pregnant women with this type of antidepressant medication despite these risks.

FDA Pregnancy Categories

Currently, the United States Food and Drug Administration uses a category system in order to rank and evaluate the safety of various drugs taken during pregnancy. This category system was introduced in the year 1979, and many other countries have implemented similar systems. This is because many drugs are tetrogens, which means that they could potentially harm a developing child. Zoloft (sertraline) is in the FDA’s “Pregnancy Category C,” which means that in animal studies, the drug has demonstrated harm/adverse effect to the developing child, but sufficient studies have not been performed using humans. Another similar antidepressant, Paxil, was recently reclassified as “Pregnancy Category D,” after new studies and market research demonstrated an adverse effect to human fetus.

Zoloft FDA Alert Lawsuits

Because taking Zoloft while pregnant has demonstrated increased risk of birth defects in several studies, many families choose to file a Zoloft lawsuit against Pfizer in order to help alleviate some of the financial burden that these injuries result in. A Zoloft lawsuit alleges that the manufacturer of the drug either did not perform sufficient testing prior to the release of the product, or that they failed in their duty to alert consumers regarding the potential for causing harm.

File a Zoloft Lawsuit: Speak to an Attorney

If your child was born with a birth injury and the mother was prescribed an antidepressant medication like Zoloft during the pregnancy, you and your family may be legally entitled to a financial settlement. Call the Willis Law Firm today in order to find out whether a Zoloft lawsuit is the right choice for you and your child. We are currently reviewing antidepressant birth defect cases in all 50 states regarding the following antidepressant medications:

  • Zoloft
  • Paxil
  • Lexapro
  • Celexa
  • Effexor
  • Prozac

Call today for your free and confidential case evaluation; all birth defect clients are taken on a contingency fee basis which means that you will not be billed any legal fees unless a recovery is made in your favor.

According to recent studies conducted by the United States Food and Drug Administration (FDA) and other groups, taking popular antacids like the purple pill Nexium for longer than a year may increase the risk of hip fractures significantly, especially in people over age 50. Nexium is one of the most commonly used prescription drugs on the entire market, taken by millions of individuals annually.

The medical professionals analyzing Nexium hypothesized that the same qualities of the drug that minimize the amount of acid in the stomach also prevent the body from absorbing an adequate amount of calcium. Calcium is essential to the development and maintenance of healthy bones in the body. This deterioration of the bones has led to reported weaker bones and Nexium related hip fractures.

Among the elderly, hip fractures may often lead to life-threatening complications. Until recently, the general perception of drugs like Nexium was that they were basically harmless. Bone fractures, more specifically hip fractures, were not listed as possible Nexium side effects when the drug was originally released and approved. The Food and Drug Administration’s (FDA) latest warning now requires Nexium and other antacids to carry a special warning on the drugs’ label about potential bone fractures including Nexium hip fractures.

For many people suffering from heartburn, they are able to find relief from over-the-counter remedies like Tums or Rolaids, but for some these over-the-counter medicines are not adequate. According to one study, patients who used drugs like Nexium for more than a year had a 44% higher chance of hip fractures than nonusers. The study claims that the longer a patient takes Nexium, the higher the risk of hip fractures. Many patients have been taking Nexium for years without knowing the potentially dangerous side effects like hip and other bone fractures.

According to reported sales figures, Nexium is the second highest selling drug in the world with sales of more than $4.5 billion last year. The study also claims that men are at a higher risk of Nexium hip fractures than women. The researchers are unsure whether this difference is due to the fact that women may be more aware of the risks of osteoporosis or that they get more calcium in their diets.

Now that AstraZeneca, the maker of Nexium, is required to carry a special warning regarding Nexium hip fractures, many people wish that they had these warnings years ago. Nexium has been on the market for more than 10 years, so there are likely very many cases of Nexium hip fractures in which the patients had no idea what caused their painful hip fractures.

Nexium Lawsuit – Speak to an Attorney

Have you or a loved one suffered from bone fractures, hip fractures, bone loss, bone density loss, or osteoporosis which you think may be attributed to taking AstraZeneca’s Nexium? If so, you may be entitled to compensation from the makers of Nexium. Our Nexium lawyers are currently accepting Nexium hip fracture lawsuits for individuals suffering from bone fractures, bone loss, and osteoporosis caused by prescription Nexium. Please call today to see if you have grounds for a Nexium hip fracture lawsuit

Mesh Erosion Surgery

When choosing a surgical procedure as a treatment method for pelvic organ prolapse or stress urinary incontinence, the last thing that a woman wants is a complication that requires further surgery. Unfortunately, many women who receive transvaginal mesh surgery for POP and SUI will experience “mesh erosion,” a very painful complication that necessitates invasive (and sometimes repeated) surgeries to correct. Alarmingly, some cases of mesh erosion can never completely be resolved even following multiple surgeries. This happens when the mesh further breaks apart during surgery, making it impossible to completely retrieve.

What is Mesh Erosion?

Mesh erosion happens when the materials of the mesh or bladder sling device are not accepted and incorporated by the various tissues in the pelvic area. Mesh, or surgical mesh, comes in both biologic and synthetic variations and is used to strengthen the weakened tissues that can lead to bladder pressure, POP and SUI. When the device erodes through the walls of the vagina, the results can be extremely painful. This pain is often increased during sexual intercourse; many of the partners of women with mesh erosion also report pain experienced to the penis during intercourse. As mentioned above, surgery is required to treat mesh erosion.

FDA Comments on Mesh Erosion

According to the United States Food and Drug Administration, the erosion of transvaginal mesh through the walls of the vagina is the “most common and consistently reported mesh-related complication” following this type of treatment. Between the years of 2005 and 2007, over one thousand women reported mesh complications to the FDA; shockingly between the years of 2008-2001 this number nearly tripled and the FDA received 2,874 adverse event reports regarding transvaginal mesh devices. In addition to mesh erosion, many other complaints regarding these products were filed ranging from vaginal scarring all the way to neuro-muscular problems. In response to these various complications, many women file mesh lawsuits in order to help them cover their treatment and emotional expenses.

File a Mesh Erosion Lawsuit: Speak to an Attorney

If you experienced mesh erosion or other complications following treatment with a transvaginal mesh or bladder sling device, you may have a legal entitlement to financial compensation. Call the Willis Law Firm today in order to receive valuable mesh erosion lawsuit information completely free and in confidence. We know that discussing these sensitive women’s issues can be potentially difficult, so we have a team of female consultants standing by for you. Although located in Houston, the Willis Law Firm is currently reviewing mesh erosion cases on a national level; all mesh erosion cases are taken on a contingency fee basis.

Pradaxa FDA Alert

In December of 2011, the United States Food and Drug Administration (FDA) released a Safety Announcement regarding recent studies conducted about Pradaxa causing internal bleeding. The Food and Drug Administration (FDA) stated that they were evaluating post-marketing (after sale) reports of severe bleeding events reported in Pradaxa patients. Pradaxa is a popular anticoagulant on the market with billions in sales.

In Pradaxa’s first year on the market, there were more than 250 deaths reportedly caused by Pradaxa related to internal bleeding. Results like that are bound to catch the eye of the Food and Drug Administration (FDA) and sure enough, they are currently reviewing the effects of Pradaxa. The Pradaxa FDA Alert states that Pradaxa is a blood thinning drug meant to lower the risk of stroke in certain patients.

At this time there is currently no Pradaxa FDA recall in effect. The FDA alert states that the bleeding caused by Pradaxa may lead to very severe and even fatal complications in patients. The Food and Drug Administration (FDA) is currently seeking to determine if the Pradaxa internal bleeding reports are occurring at higher rates than normal.

Pradaxa has been submitted into the Food and Drug Administration’s (FDA) Adverse Events Reporting System (AERS) to further investigate what adverse effects may be caused by Pradaxa and to determine if these Pradaxa internal bleeding deaths are occurring at a higher rate than expected.

Pradaxa and Xarelto are both fairly new blood thinning drugs on the market. Previous to their introduction, the most common anticoagulant treatment was warfarin. Pradaxa is preferred by many because it is believed to be easier to dose for patients, requiring fewer blood tests and less examination. However, if Pradaxa or Xarelto are causing significantly more internal bleeding deaths, then it may not be worth the risk according to many health experts.

One reason that warfarin is believed to be safer than Xarelto or Pradaxa is that in the event of warfarin internal bleeding; patients may supplement their intake with Vitamin K to offset much of the internal bleeding danger. For patients taking Pradaxa however, Vitamin K does not have the same negating effects on the internal bleeding.

The manufacturer of Pradaxa, German pharmaceutical company Boehringer Ingelheim, has admitted that roughly 260 cases of fatal internal bleeding have been linked to their drug Pradaxa. They claim that the number of Pradaxa deaths is below the average rate, but the trials are not conclusive. It is impossible to know if the 260 reported Pradaxa deaths are the only Pradaxa deaths which have occurred.

Pradaxa / Xarelto Lawsuit – Speak To a Lawyer

If you or a loved one took Pradaxa or Xarelto and have suffered from internal bleeding or know of someone who has suffered or died from internal bleeding which you believe may be caused by Xarelto or Pradaxa, you may be entitled to financial compensation. Potential Pradaxa and Xarelto internal bleeding lawsuits are currently being reviewed. Please contact our law firm immediately to see if you have a internal bleeding case caused by Xarelto or Pradaxa.

FDA Yaz Warnings

Yaz Birth Control Pill Pack

The United States Food and Drug Administration is currently conducting an evaluation of an increased risk of blood clots associated with Yaz, a birth control pill that contains drospirenone. Yaz has already been the subject of FDA warnings before in 2008, when their television advertisements were deemed as misleading the public. Yaz’s commercials suggested that the drug had also been approved for the treatment of acne and PMS in addition to preventing pregnancy. In reality, neither of these claims was validated by evidence. Furthermore, the ads were criticized by the FDA as suggesting that Yaz was “safer” than other types of oral contraceptives without any substantial evidence or clinical proof. Recent studies have actually indicated that oral contraceptives with drospironine, including Yaz, actually carry with them higher risks of blood clots than other birth control methods.

Yaz Blood Clot Studies

Bayer claims that its product Yaz is “as safe and effective” as other birth control pills, and according to two clinical studies (both of which were funded by Bayer) this is true. However, four other independently conducted studies (not funded by Bayer) regarding Yaz found increased risks of blood clots. When presented with the evidence of one of these studies that used nearly 1 million women, Bayer chose not to respond. Fortunately, the FDA has not taken the same approach. When presented with the information of studies regarding this increased risk and its conflict with the studies conducted by Bayer, the FDA decided to fund its own study regarding these safety issues. The findings of the FDA study have not yet been released.

Yaz Lawsuit

When taking Yaz results in a blood clot, the results can be devastating. Deep vein thrombosis, one type of blood clot linked to Yaz, can sometimes result in a condition called a pulmonary embolism. Pulmonary embolisms can be life threatening, especially if not treated quickly. Other blood clots can lead to strokes as well as other serious medical problems. Many women who suffer these related injuries file a Yaz lawsuit against Bayer. These lawsuits often allege that Bayer was aware of these increased risks and did not warn them adequately. Furthermore, some Yaz lawsuits assert that Bayer actually tried to cover up related information in order to protect the company’s financial interests.

File a Yaz Lawsuit: Speak to an Attorney

If you have experienced a blood clot or related medical complication and were prescribed Yaz, you may have a legal right to financial compensation. Call the Willis Law Firm today, and we will provide you with a Yaz lawsuit evaluation free of cost or obligation. We accept all Yaz cases on a contingency fee basis, so you will not be responsible for any legal fees unless a recovery is made in your favor. Currently our firm is reviewing cases for the following birth controls containing drospironine on a national scale: Yaz, Yasmin, and Ocella.